OmniAb (OABI) Return on Equity [ROE] (2022 - 2026)
OmniAb (OABI) reported Return on Equity [ROE] of -16.93% for Q2 2026, up 6.79 percentage points from -23.72% a year earlier and up 3.57 percentage points from the prior quarter.
Powered by 
Analysis
OmniAb (OABI) Return on Equity [ROE] (2022 - 2026) Analysis & Trends
For FY2025, OmniAb posted Return on Equity [ROE] of -23.36%, down 2.76 percentage points from FY2024.
- Return on Equity [ROE] has declined for three consecutive years, with a three-year change of -15.60 percentage points (FY2022 to FY2025).
- By year, Return on Equity [ROE] came in at -20.60% in FY2024 (-5.17 pp), -15.43% in FY2023 (-7.67 pp) and -7.76% in FY2022.
- The Q2 2026 figure ranks as the highest quarterly Return on Equity [ROE] since Q4 2023.
- Year over year, Return on Equity [ROE] gained in two of the last eight quarters, with an average year-over-year change of -2.30 percentage points.
- The high point for year-over-year Return on Equity [ROE] in five years was Q3 2023 (a gain of 19.06 percentage points); the low point was Q1 2024 (a drop of 14.12 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -20.50% (Q1 2026), -23.80% (Q4 2025) and -23.60% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 84.40% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.97% |
| 10 | OmniAb | 708.05 Mn | 493.46 Mn | 12.81 Mn | -16.93% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -16.93% |
| Mar 31, 2026 | -20.50% |
| Dec 31, 2025 | -23.80% |
| Sep 30, 2025 | -23.60% |
| Jun 30, 2025 | -23.72% |
| Mar 31, 2025 | -21.84% |
| Dec 31, 2024 | -21.41% |
| Sep 30, 2024 | -21.51% |
| Jun 30, 2024 | -20.95% |
| Mar 31, 2024 | -20.61% |
| Dec 31, 2023 | -15.84% |
| Sep 30, 2023 | -9.04% |
| Jun 30, 2023 | -7.89% |
| Mar 31, 2023 | -6.49% |
| Dec 31, 2022 | -7.78% |
| Sep 30, 2022 | -28.10% |
| Jun 30, 2022 | -23.09% |
| Mar 31, 2022 | -18.24% |
API Access
OmniAb Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=OABI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "OABI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=OABI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();